selected scholarly activity
-
academic article
- Management of Non-ST-Elevation Myocardial Infarction in Elderly Patients: Time to Consider Frailty and Quality of Life.. Canadian Journal of Cardiology. 34:241-243. 2018
- Enhancing Knowledge and InterProfessional care for Heart Failure (EKWIP-HF) in long-term care: a pilot study.. Pilot Feasibility Stud. 4:9. 2018
- 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure.. Canadian Journal of Cardiology. 33:1342-1433. 2017
- Implementation of an interprofessional communication and collaboration intervention to improve care capacity for heart failure management in long-term care.. Journal of Interprofessional Care. 31:583-592. 2017
- Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study.. The Lancet Global Health. 5:e665-e672. 2017
- Evaluating the Performance of a Single-Item, Global, Estimate of Missed Nursing Care.. Journal of Nursing Measurement. 25:121-141. 2017
- Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials.. European Heart Journal. 38:742-750. 2017
- The role of unregulated care providers in managing heart failure patients in long-term care facilities.. Journal of Clinical Nursing. 26:849-861. 2017
- Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.. Journal of Cardiac Failure. 23:20-28. 2017
- Managing Heart Failure in Long-Term Care: Recommendations from an Interprofessional Stakeholder Consultation.. Canadian Journal on Aging/La Revue canadienne du vieillissment/Canadian Public Policy/Analyse de Politiques. 35:447-464. 2016
- The Development and Feasibility Assessment of Canadian Quality Indicators for Atrial Fibrillation.. Canadian Journal of Cardiology. 32:1566-1569. 2016
- Canadian Cardiovascular Society Quality Indicators for Heart Failure.. Canadian Journal of Cardiology. 32:1038.e5-1038.e9. 2016
- Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.. European Journal of Heart Failure. 18:1021-1031. 2016
- Technology-Enabled Remote Monitoring and Self-Management - Vision for Patient Empowerment Following Cardiac and Vascular Surgery: User Testing and Randomized Controlled Trial Protocol.. JMIR Research Protocols. 5:e149. 2016
- Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.. New England Journal of Medicine. 374:2009-2020. 2016
- Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.. New England Journal of Medicine. 374:2032-2043. 2016
- Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.. New England Journal of Medicine. 374:2021-2031. 2016
- Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE).. Diabetes Care. 39:709-716. 2016
- The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice.. Canadian Journal of Cardiology. 32:296-310. 2016
- Heart Failure in Africa, Asia, the Middle East and South America: The INTER-CHF study.. International Journal of Cardiology. 204:133-141. 2016
- Importance of early cardiac rehabilitation on changes in exercise capacity: a retrospective pilot study.. Canadian Journal of Applied Physiology Applied Physiology, Nutrition and Metabolism. 40:1314-1317. 2015
- Effects of resistance training combined with moderate-intensity endurance or low-volume high-intensity interval exercise on cardiovascular risk factors in patients with coronary artery disease.. Journal of Science and Medicine in Sport. 18:637-642. 2015
- The CREATE Method for Expressing Continuous Outcome Data in Absolute Terms for Use in Patient Treatment Decision Aids: A Validation Study.. Medical Decision Making. 35:959-966. 2015
- Heart failure in low- and middle-income countries: background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF).. American Heart Journal. 170:627-634.e1. 2015
- Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.. European Journal of Heart Failure. 17:925-935. 2015
- Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study.. European Journal of Heart Failure. 17:809-817. 2015
- Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients With Heart Failure and Preserved Systolic Function Trial.. Circulation: Heart Failure. 8:717-724. 2015
- Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.. JACC: Heart Failure. 3:478-486. 2015
- The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).. JACC: Heart Failure. 3:429-441. 2015
- Mobilization patterns of patients after an acute myocardial infarction: a pilot study.. Clinical Nursing Research. 24:139-155. 2015
- Evidence based application of BNP/NT-proBNP testing in heart failure.. Clinical Biochemistry. 48:236-246. 2015
- Physicians' perceptions of capacity building for managing chronic disease in seniors using integrated interprofessional care models.. Canadian Family Physician. 61:e148-e157. 2015
- Cerebral hypoperfusion is exaggerated with an upright posture in heart failure: impact of depressed cardiac output.. JACC: Heart Failure. 3:168-175. 2015
- Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction. European Journal of Heart Failure. 17:169-176. 2015
- International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.. Circulation. 131:43-53. 2015
- The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications.. Canadian Journal of Cardiology. 31:3-16. 2015
- A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction. European Journal of Heart Failure. 16:1175-1182. 2014
- History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction.. Circulation: Heart Failure. 7:960-966. 2014
- Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment.. Journal of the American College of Cardiology. 64:1106-1113. 2014
- Managing heart failure in the long-term care setting: nurses' experiences in Ontario, Canada.. Nursing Research. 63:357-365. 2014
- Perspectives of Primary-Care Providers on Heart Failure in Long-Term Care Homes.. Canadian Journal on Aging/La Revue canadienne du vieillissment/Canadian Public Policy/Analyse de Politiques. 33:320-335. 2014
- A systematic review of BNP and NT-proBNP in the management of heart failure: overview and methods.. Heart Failure Reviews. 19:413-419. 2014
- B-type natriuretic peptide-guided therapy: a systematic review.. Heart Failure Reviews. 19:553-564. 2014
- BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review.. Heart Failure Reviews. 19:453-470. 2014
- BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure (vol 19, pg 471, 2014). Heart Failure Reviews. 19:565-565. 2014
- BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure.. Heart Failure Reviews. 19:471-505. 2014
- Incremental predictive value of natriuretic peptides for prognosis in the chronic stable heart failure population: a systematic review.. Heart Failure Reviews. 19:521-540. 2014
- Incremental value of natriuretic peptide measurement in acute decompensated heart failure (ADHF): a systematic review.. Heart Failure Reviews. 19:507-519. 2014
- Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review.. Heart Failure Reviews. 19:439-451. 2014
- Prediction of clinical outcomes using B-type natriuretic peptides in the general population: a systematic review.. Heart Failure Reviews. 19:541-551. 2014
- Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence.. Heart Failure Reviews. 19:421-438. 2014
- Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve). European Journal of Heart Failure. 16:778-787. 2014
- Development of a patient decision aid for people with refractory angina: protocol for a three-phase pilot study.. Health and Quality of Life Outcomes. 12:93. 2014
- Cognitive function and self-care management in older patients with heart failure.. European Journal of Cardiovascular Nursing. 13:277-284. 2014
- The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: focus on rehabilitation and exercise and surgical coronary revascularization.. Canadian Journal of Cardiology. 30:249-263. 2014
- Impact of self-management interventions on stable angina symptoms and health-related quality of life: a meta-analysis.. BMC Cardiovascular Disorders. 14:14. 2014
- Brachial artery endothelial responses during early recovery from an exercise bout in patients with coronary artery disease.. BioMed Research International. 2014:591918. 2014
- Living and dying with heart failure in long-term care: experiences of residents and their family members.. International Journal of Palliative Nursing. 19:375-382. 2013
- Low-volume, high-intensity interval training in patients with CAD.. Medicine and Science in Sports and Exercise Medicine and science in sports. 45:1436-1442. 2013
- Heart failure--related mortality and hospitalization in the year following admission to a long-term care facility: the geriatric outcomes and longitudinal decline in heart failure (GOLD-HF) study.. Journal of Cardiac Failure. 19:468-477. 2013
- Heart rate recovery and heart rate variability are unchanged in patients with coronary artery disease following 12 weeks of high-intensity interval and moderate-intensity endurance exercise training.. Canadian Journal of Applied Physiology Applied Physiology, Nutrition and Metabolism. 38:644-650. 2013
- The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure.. Canadian Journal of Cardiology. 29:168-181. 2013
- The Value of Admission Clinical Data for Diagnosing Heart Failure in Long-term Care.. Can Geriatr J. 16:147-155. 2013
- The measurement of uncertainty in caregivers of patients with heart failure.. Journal of Nursing Measurement. 21:23-42. 2013
- Flow-mediated dilation is acutely improved after high-intensity interval exercise.. Medicine and Science in Sports and Exercise Medicine and science in sports. 44:2057-2064. 2012
- Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection Fraction The Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial. Circulation: Heart Failure. 5:571-578. 2012
- Response to Letters Regarding Article, "Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction". Circulation. 126:E64-E65. 2012
- The older patient with heart failure: high risk for frailty and cognitive impairment.. Expert Review of Cardiovascular Therapy. 10:779-795. 2012
- Assessment of Long-Term Effects of Irbesartan on Heart Failure With Preserved Ejection Fraction as Measured by the Minnesota Living With Heart Failure Questionnaire in the Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) Trial. Circulation: Heart Failure. 5:217-225. 2012
- Predicting heart failure mortality in frail seniors: comparing the NYHA functional classification with the Resident Assessment Instrument (RAI) 2.0.. International Journal of Cardiology. 155:75-80. 2012
- Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction.. Circulation. 124:2491-2501. 2011
- The Dutch Objective Burden Inventory: validity and reliability in a Canadian population of caregivers for people with heart failure.. European Journal of Cardiovascular Nursing. 10:234-240. 2011
- What are the effects of care rationing?. Nursing New Zealand (Wellington, N.Z. : 1995). 17:34. 2011
- Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction Findings From the I-PRESERVE Trial. Circulation: Heart Failure. 4:569-577. 2011
- Relation of Peripheral Collagen Markers to Death and Hospitalization in Patients With Heart Failure and Preserved Ejection Fraction Results of the I-PRESERVE Collagen Substudy. Circulation: Heart Failure. 4:561-568. 2011
- Heart failure.. American Family Physician. 2011:467-469. 2011
- Clinical, demographic and functional characteristics associated with pharmacotherapy for heart failure in older home care clients: a retrospective, population-level, cross-sectional study.. Drugs and Aging. 28:561-573. 2011
- Six-year follow-up of a randomised controlled trial examining hospital versus home-based exercise training after coronary artery bypass graft surgery. Heart British Heart Journal. 97:1169-1174. 2011
- The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care.. Canadian Journal of Cardiology. 27:319-338. 2011
- Screening for cognitive deficits using the Montreal cognitive assessment tool in outpatients ≥65 years of age with heart failure.. American Journal of Cardiology. 107:1203-1207. 2011
- Clinical, Demographic and Functional Characteristics Associated with Pharmacotherapy for Heart Failure in Older Home Care Clients. Drugs and Aging. 28:561-573. 2011
- Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE).. Circulation: Heart Failure. 4:27-35. 2011
- Should treatment for heart failure with preserved ejection fraction differ from that for heart failure with reduced ejection fraction?. British Medical Journal BMJ (Clinical research ed.). 341:c4202. 2010
- Hypertension as an underlying factor in heart failure with preserved ejection fraction.. Journal of Clinical Hypertension. 12:277-283. 2010
- Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure.. PLoS ONE. 5:e9946. 2010
- Randomised controlled trial: Compared with low-dose losartan, high-dose losartan decreases risk of death or hospital admission for heart failure in people with heart failure who are intolerant to ACE inhibitors.. Evidence-Based Medicine. 15:51-52. 2010
- The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs. Canadian Journal of Cardiology. 26:185-202. 2010
- Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial.. Circulation. 121:1393-1405. 2010
- Heart failure.. American Family Physician. 2010:182-184. 2010
- Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial.. Journal of Cardiac Failure. 16:128-134. 2010
- N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study.. American Heart Journal. 158:S37-S44. 2009
- Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction.. American Heart Journal. 158:S72-S77. 2009
- Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker.. Therapeutic Advances in Cardiovascular Disease. 3:113-121. 2009
- Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: Diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Canadian Journal of Cardiology. 25:85-105. 2009
- Irbesartan in patients with heart failure and preserved ejection fraction.. New England Journal of Medicine. 359:2456-2467. 2008
- Cardiovascular aging and exercise in healthy older adults.. Clinical Journal of Sport Medicine. 18:479-485. 2008
- Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.. American Journal of Cardiology. 102:733-737. 2008
- Diabetes, left ventricular systolic dysfunction, and chronic heart failure.. European Heart Journal. 29:1224-1240. 2008
- Puzzling practice: a strategy for working with clinical practice issues.. International Journal of Nursing Practice. 14:94-100. 2008
- A systematic review of BNP as a predictor of prognosis in persons with coronary artery disease.. Clinical Biochemistry. 41:260-265. 2008
- BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction.. European Journal of Heart Failure. 10:252-259. 2008
- Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: a systematic review.. Clinical Biochemistry. 41:250-259. 2008
- Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary care.. Clinical Biochemistry. 41:240-249. 2008
- Monitoring the response to pharmacologic therapy in patients with stable chronic heart failure: is BNP or NT-proBNP a useful assessment tool?. Clinical Biochemistry. 41:266-276. 2008
- Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP.. Clinical Biochemistry. 41:231-239. 2008
- Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial.. European Journal of Heart Failure. 10:149-156. 2008
- Relationships between plasma levels of matrix metalloproteinases and neurohormonal profile in patients with heart failure. European Journal of Heart Failure. 10:125-128. 2008
- Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.. Canadian Journal of Cardiology. 24:21-40. 2008
- The effects of exercise training on insulin resistance in patients with coronary artery disease.. European Journal of Cardiovascular Prevention and Rehabilitation Journal of Cardiovascular Risk. 14:803-808. 2007
- Effect of aerobic vs combined aerobic-strength training on 1-year, post-cardiac rehabilitation outcomes in women after a cardiac event.. Journal of Rehabilitation Medicine Scandinavian Journal of Rehabilitation Medicine. 39:730-735. 2007
- In reply to Drs. Parashar and Varma. Journal of the American Geriatrics Society. 55:1303-1304. 2007
- Diastolic dysfunction and heart failure - Reply. Journal of the American College of Cardiology. 50:79-80. 2007
- Necessary cautions when considering digoxin in heart failure.. CMAJ. 176:644-645. 2007
- Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES.. Journal of the American College of Cardiology. 49:687-694. 2007
- Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.. Canadian Journal of Cardiology. 23:21-45. 2007
- Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM.. European Journal of Heart Failure. 9:83-91. 2007
- Heart failure and cognitive impairment: challenges and opportunities.. Clinical Interventions in Aging. 2:209-218. 2007
- Heart failure.. Clinical evidence. 2007. 2007
- Association between psychotropic drug use and heart failure therapy in elderly long-term care residents.. Journal of the American Geriatrics Society. 54:1973-1975. 2006
- Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure.. Journal of Cardiac Failure. 12:514-519. 2006
- Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure.. Evidence report/technology assessment. 1-147. 2006
- Effect of exercise training on myocardial blood flow in patients with stable coronary artery disease.. American Heart Journal. 151:1324.e11-1324.e18. 2006
- Heart failure.. Clinical evidence. 118-139. 2006
- Comparison of fondaparinux and enoxaparin in acute coronary syndromes.. New England Journal of Medicine. 354:1464-1476. 2006
- Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management.. Canadian Journal of Cardiology. 22:23-45. 2006
- Exercise and the heart failure patient: aerobic vs strength training--is there a need for both?. Progress in cardiovascular nursing. 21:146-150. 2006
- Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure.. JAMA - Journal of the American Medical Association. 294:1794-1798. 2005
- The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design.. Journal of Cardiac Failure. 11:576-585. 2005
- Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.. American Journal of Cardiology. 96:698-704. 2005
- Growth hormone therapy in heart failure: a novel therapy worthy of further consideration?. Expert Opinion on Investigational Drugs. 14:1009-1018. 2005
- Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice. European Journal of Heart Failure. 7:710-721. 2005
- Patient perception of the effect of treatment with candesartan in heart failure. Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.. European Journal of Heart Failure. 7:650-656. 2005
- Digoxin prescribing for heart failure in elderly residents of long-term care facilities.. Canadian Journal of Cardiology. 21:281-286. 2005
- ACE inhibitors in heart failure: what more do we need to know?. American Journal of Cardiovascular Drugs. 5:351-359. 2005
- Heart failure.. Clinical evidence. 115-143. 2004
- Metabolic profile and exercise capacity outcomes: their relationship to overweight and obesity in a Canadian cardiac rehabilitation setting.. Journal of Cardiopulmonary Rehabilitation Journal of Cardiopulmonary Rehabilitation and Prevention. 24:405-413. 2004
- Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.. Circulation. 110:2618-2626. 2004
- Differences in sustainability of exercise and health-related quality of life outcomes following home or hospital-based cardiac rehabilitation.. European Journal of Cardiovascular Prevention and Rehabilitation Journal of Cardiovascular Risk. 11:313-319. 2004
- Management of heart failure in Canadian long-term care facilities.. Canadian Journal of Cardiology. 20:963-969. 2004
- Valsartan plus captopril did not improve survival more than captopril alone after myocardial infarction.. ACP journal club. 141:3. 2004
- Heart failure.. Clinical evidence. 122-148. 2004
- Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). British Medical Journal BMJ (Clinical research ed.). 328:189-192. 2004
- The impact of an outpatient heart failure clinic on hospital costs and admissions.. International journal of health care quality assurance incorporating Leadership in health services Leadership in Health Services. 17:i-xi. 2004
- Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. New England Journal of Medicine. 349:1893-1906. 2003
- Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure.. European Heart Journal. 24:1727-1734. 2003
- Heart failure.. Clinical evidence. 95-118. 2003
- The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure.. Canadian Journal of Cardiology. 19:347-356. 2003
- Growth hormone therapy in heart failure: where are we now?. Congestive Heart Failure. 9:84-90. 2003
- The role of angiotensin II receptor blockers in the treatment of heart failure patients.. Congestive Heart Failure. 9:29-34. 2003
- Heart failure.. Clinical evidence. 60-81. 2002
- A controlled trial of hospital versus home-based exercise in cardiac patients.. Medicine and Science in Sports and Exercise Medicine and science in sports. 34:1544-1550. 2002
- Effects of exercise training in patients with heart failure: the Exercise Rehabilitation Trial (EXERT).. American Heart Journal. 144:23-30. 2002
- Heart failure.. Clinical evidence. 57-78. 2002
- Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface.. Journal of Biological Chemistry. 277:7529-7539. 2002
- Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials.. Journal of the American College of Cardiology. 39:463-470. 2002
- Heart failure (Reprinted from Clin Evid, vol 5, pg 43-62, 2001). American Family Physician. 65:99-102. 2002
- Heart failure.. American Family Physician. 65:99-102. 2002
- The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure.. Canadian Journal of Cardiology. 17 Suppl E:5E-25E. 2001
- Acute cardiovascular responses to leg-press resistance exercise in heart transplant recipients.. International Journal of Cardiology. 81:61-74. 2001
- Acute precipitants of congestive heart failure exacerbations.. Archives of Internal Medicine A.M.A. archives of internal medicine Archives of internal medicine (Chicago, Ill. : 1908). 161:2337-2342. 2001
- Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure.. American Heart Journal. 142:698-703. 2001
- Angiotensin receptor blockers for heart failure.. Cochrane Database of Systematic Reviews. 2001
- Functional capacity in patients with congestive heart failure.. Journal of Cardiac Failure. 6:214-219. 2000
- Effect of a preoperative intervention on preoperative and postoperative outcomes in low-risk patients awaiting elective coronary artery bypass graft surgery. A randomized, controlled trial.. Annals of Internal Medicine. 133:253-262. 2000
- Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.. European Heart Journal. 21:1368-1375. 2000
- Drug treatment in heart failure.. British Medical Journal BMJ (Clinical research ed.). 320:1188-1192. 2000
- Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy - The randomized evaluation of strategies for left ventricular dysfunction pilot study. Circulation. 101:378-384. 2000
- Exercise training for patients with chronic heart failure reduced mortality and cardiac events and improved quality of life.. Western Journal of Medicine. 172:28. 2000
- Validity of predicting mean arterial blood pressure during exercise.. Medicine and Science in Sports and Exercise Medicine and science in sports. 31:1876-1879. 1999
- Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.. Circulation. 100:1056-1064. 1999
- The role of digitalis in the treatment of heart failure.. Coronary Artery Disease. 10:353-360. 1999
- Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction.. British Medical Journal BMJ (Clinical research ed.). 318:1400-1402. 1999
- Combination of diet and exercise effective in reducing LDL-cholesterol.. Evidence-based Cardiovascular Medicine. 2:95. 1998
- The effect of beta-blockade on plasma potassium concentrations and muscle excitability following static exercise.. Pflugers Archiv European Journal of Physiology. 436:449-456. 1998
- Muscle performance and enzymatic adaptations to sprint interval training.. Journal of Applied Physiology Journal of Applied Physiology Respiratory Environmental and Exercise Physiology. 84:2138-2142. 1998
- Clinical workload decreases the level of aerobic fitness in housestaff physicians.. Journal of Cardiopulmonary Rehabilitation Journal of Cardiopulmonary Rehabilitation and Prevention. 18:216-220. 1998
- Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.. Canadian Journal of Cardiology. 13:1166-1174. 1997
- LV internal dimensions predicted an increased risk of CHF in patients free of MI.. Evidence-based Cardiovascular Medicine. 1:95. 1997
- Enhanced pulmonary and active skeletal muscle gas exchange during intense exercise after sprint training in men.. Journal of Physiology. 501 ( Pt 3):703-716. 1997
- Sprint training enhances ionic regulation during intense exercise in men.. Journal of Physiology. 501 ( Pt 3):687-702. 1997
- Effect of progressive incremental exercise and beta-adrenergic blockade on erythrocyte ion concentrations.. Canadian Journal of Physiology and Pharmacology. 75:19-25. 1997
- Aerobic exercise and normotensive adults: a meta-analysis.. Clinical Journal of Sport Medicine. 6:213. 1996
- The relationship between plasma potassium, muscle membrane excitability and force following quadriceps fatigue.. Pflugers Archiv European Journal of Physiology. 432:43-49. 1996
- The role of resistance training in patients with cardiac disease.. European Journal of Cardiovascular Prevention and Rehabilitation Journal of Cardiovascular Risk. 3:160-166. 1996
- Circulatory responses to weight lifting, walking, and stair climbing in older males.. Journal of the American Geriatrics Society. 44:121-125. 1996
- Comparison of hemodynamic responses to cycling and resistance exercise in congestive heart failure secondary to ischemic cardiomyopathy.. American Journal of Cardiology. 76:977-979. 1995
- COLLABORATIVE CARDIOVASCULAR CLINICAL-TRIALS IN CANADA. Canadian Journal of Cardiology. 11:649-657. 1995
- Right ventricular diastolic collapse without hemodynamic compromise in a patient with large, bilateral pleural effusions.. Journal of the American Society of Echocardiography. 8:551-553. 1995
- Effects of exercise training in patients with congestive heart failure: a critical review.. Journal of the American College of Cardiology. 25:789-796. 1995
- K+ and Lac- distribution in humans during and after high-intensity exercise: role in muscle fatigue attenuation?. Journal of Applied Physiology Journal of Applied Physiology Respiratory Environmental and Exercise Physiology. 78:765-777. 1995
- Effect of selective and nonselective beta-blockade on skeletal muscle excitability and fatiguability.. Journal of Applied Physiology Journal of Applied Physiology Respiratory Environmental and Exercise Physiology. 76:2461-2466. 1994
- PLASMA-VOLUME AND ION REGULATION DURING EXERCISE AFTER LOW-CARBOHYDRATE AND HIGH-CARBOHYDRATE DIETS. American Journal of Physiology. 266:R1896-R1906. 1994
- Plasma volume and ion regulation during exercise after low- and high-carbohydrate diets.. American Journal of Physiology. 266:R1896-R1906. 1994
- Role of angiotensin converting enzyme inhibitors in patients with left ventricular dysfunction and congestive heart failure.. European Heart Journal. 15 Suppl B:9-13. 1994
- Effect of training on the blood pressure response to weight lifting.. Canadian Journal of Applied Physiology Applied Physiology, Nutrition and Metabolism. 19:60-74. 1994
- Left ventricular response in healthy young men during heavy-intensity weight-lifting exercise.. Journal of Applied Physiology Journal of Applied Physiology Respiratory Environmental and Exercise Physiology. 75:2703-2710. 1993
- PYRUVATE-DEHYDROGENASE ACTIVITY AND ACETYL GROUP ACCUMULATION DURING EXERCISE AFTER DIFFERENT DIETS. American Journal of Physiology. 265:E752-E760. 1993
- Pyruvate dehydrogenase activity and acetyl group accumulation during exercise after different diets.. American Journal of Physiology. 265:E752-E760. 1993
- Weight-training-induced attenuation of the circulatory response of older males to weight lifting.. Journal of Applied Physiology Journal of Applied Physiology Respiratory Environmental and Exercise Physiology. 74:1056-1060. 1993
- The effects of variations in the anti-G straining maneuver on blood pressure at +Gz acceleration.. Aviation Space and Environmental Medicine. 64:126-131. 1993
- Comparison of blood pressure response to isokinetic and weight-lifting exercise.. European Journal of Applied Physiology and Occupational Physiology. 67:115-120. 1993
- Erythrocyte ion regulation across inactive muscle during leg exercise.. Canadian Journal of Physiology and Pharmacology. 70:1625-1633. 1992
- Factors affecting blood pressure during heavy weight lifting and static contractions.. Journal of Applied Physiology Journal of Applied Physiology Respiratory Environmental and Exercise Physiology. 73:1590-1597. 1992
- BLOOD ION REGULATION DURING REPEATED MAXIMAL EXERCISE AND RECOVERY IN HUMANS. American Journal of Physiology. 262:R126-R136. 1992
- Blood ion regulation during repeated maximal exercise and recovery in humans.. American Journal of Physiology. 262:R126-R136. 1992
- Contribution of erythrocytes to the control of the electrolyte changes of exercise.. Canadian Journal of Physiology and Pharmacology. 69:984-993. 1991
- Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction.. American Journal of Cardiology. 67:1084-1089. 1991
- Usefulness of weightlifting training in improving strength and maximal power output in coronary artery disease.. American Journal of Cardiology. 67:939-945. 1991
- Effects of steady state exercise on the power spectrum of heart rate variability.. Medicine and Science in Sports and Exercise Medicine and science in sports. 23:428-434. 1991
- Factors contributing to increased muscle fatigue with beta-blockers.. Canadian Journal of Physiology and Pharmacology. 69:254-261. 1991
- Weightlifting training in cardiac patients. Considerations.. Sports Medicine. 10:355-364. 1990
- Comparison of direct and indirect measures of systemic arterial pressure during weightlifting in coronary artery disease.. American Journal of Cardiology. 66:1065-1069. 1990
- ROLE OF NONWORKING MUSCLE ON BLOOD METABOLITES AND IONS WITH INTENSE INTERMITTENT EXERCISE. American Journal of Physiology. 258:R1486-R1494. 1990
- Role of nonworking muscle on blood metabolites and ions with intense intermittent exercise.. American Journal of Physiology. 258:R1486-R1494. 1990
- RENAL RESPONSES TO EXERCISE-INDUCED LACTIC-ACIDOSIS. American Journal of Physiology. 257:R102-R108. 1989
- Renal responses to exercise-induced lactic acidosis.. American Journal of Physiology. 257:R102-R108. 1989
- Cardiopulmonary exercise testing.. Clinics in Chest Medicine. 10:277-291. 1989
- Muscle glycogenolysis and H+ concentration during maximal intermittent cycling.. Journal of Applied Physiology Journal of Applied Physiology Respiratory Environmental and Exercise Physiology. 66:8-13. 1989
- Measurement of cardiac output by CO2 rebreathing in unsteady state exercise.. Chest. 92:777-782. 1987
- Heart rate variability power spectrogram as a potential noninvasive signature of cardiac regulatory system response, mechanisms, and disorders.. Heart and Vessels. 3:33-41. 1987
-
conference paper
- OPTIMAL USAGE OF SACUBITRIL/VALSARTAN FOR HEART FAILURE TREATMENT IN CANADA POTENTIALLY REDUCES MORTALITY, HOSPITALIZATIONS AND EARLY DISCHARGE RE-ADMISSIONS. Value in Health. A605-A605. 2017
- Potential Mortality Reduction with Optimal Usage of sacubitril/valsartan Therapy for the Treatment of Heart Failure in Canada. Circulation. 2017
- Potential Mortality Reduction with Optimal Usage of sacubitril/valsartan Therapy for the Treatment of Heart Failure in Canada. Circulation. 2017
- A Prediction Model for Sudden Cardiac Death in Patients With Heart Failure and Preserved Ejection Fraction. Circulation. 2014
- Which formula for estimating glomerular filtration rate is the better predictor of outcomes in heart failure with preserved ejection fraction? An analysis from the I-Preserve trial. European Heart Journal. 2-2. 2014
- Risk of Clinical Outcomes and Baseline Atrial Fibrillation: Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial. Circulation. 2013
- Why Are patients With Heart Failure and Preserved Ejection Fraction Hospitalized? Data From I-PRESERVE. Circulation. 2013
- Altered Executive Function in Older Heart Failure Patients at Hospital Discharge: New Data from the Montreal Cognitive Assessment Tool. Journal of Cardiac Failure. S83-S84. 2013
- MORBIDITY AND MORTALITY IN DIABETICS WITH HEART FAILURE AND A PRESERVED EJECTION FRACTION: RESULTS FROM THE I-PRESERVE TRIAL. Journal of the American College of Cardiology. E706-E706. 2013
- High Prevalence of Cognitive Impairment in Older Heart Failure Patients at Hospital Discharge. Circulation. 2012
- COGNITIVE IMPAIRMENT IN OLDER HEART FAILURE PATIENTS AT HOSPITAL DISCHARGE AND ITS IMPACT ON SELF-CARE - RESULTS OF A PROSPECTIVE STUDY. Canadian Journal of Cardiology. S415-S416. 2012
- EVALUATING AWARENESS AND KNOWLEDGE OF THE CANADIAN CARDIOVASCULAR SOCIETY'S GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF HEART FAILURE AMONG RESIDENTS IN GENERAL INTERNAL AND FAMILY MEDICINE: A PILOT STUDY. Canadian Journal of Cardiology. S343-S343. 2012
- NEW INSIGHT INTO PREDICTORS OF SELF-CARE CONFIDENCE IN OLDER PATIENTS WITH HEART FAILURE. Canadian Journal of Cardiology. S422-S422. 2012
- THE ASSOCIATION BETWEEN COGNITIVE FUNCTION AND SELF-CARE IN OLDER PATIENTS WITH HEART FAILURE. Canadian Journal of Cardiology. S347-S347. 2012
- Cognitive Function in Older Heart Failure Patients Is Similar to Older Patients Following Stroke. Journal of Cardiac Failure. S65-S65. 2012
- DEPRESSION AND NEUROHORMONAL MODULATION IN PATIENTS UNDERGOING TREATMENT FOR CONGESTIVE HEART FAILURE: RANDOMIZED EVALUATION OF STRATEGIES FOR LEFT VENTRICULAR DYSFUNCTION SUBSTUDY. Journal of the American College of Cardiology. E899-E899. 2012
- Predictors of early ambulation after acute myocardial infarction. European Journal of Cardiovascular Nursing. S40-S40. 2012
- Does the 6 Minute Walk Test Provide Useful Prognostic Information in Systolic Heart Failure Patients?. Circulation. 2011
- Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients with Heart Failure and Preserved Ejection Fraction: The I-PRESERVE Trial. Circulation. 2011
- Canadian Heart Failure Patient and Caregiver Emotions. Journal of Cardiac Failure. S80-S80. 2011
- PREDICTORS OF UNCERTAINTY IN CAREGIVERS OF PATIENTS WITH HEART FAILURE - A LONGITUDINAL STUDY. Canadian Journal of Cardiology. 151D-152D. 2010
- THE CANADIAN CARDIOVASCULAR SOCIETY GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF HEART FAILURE: RESULTS OF A 5-YEAR CLOSED LOOP IMPLEMENTATION PROGRAM. Canadian Journal of Cardiology. 124D-124D. 2010
- The Dutch Objective Burden Inventory - Validity and Reliability Testing in Canada. Journal of Cardiac Failure. S114-S114. 2010
- Obesity and Its Relationship to Adverse Cardiovascular Outcomes in Older Patients With Heart Failure and Preserved Ejection Fraction in the I-PRESERVE Trial. Circulation. S757-S758. 2009
- Quality of Life Questionnaire Responsiveness and Lack of Relationship to Functional Capacity: Findings From the Exercise Rehabilitation Trial (EXERT). Circulation. S511-S511. 2009
- The Relation of Quality of Life Score to Outcome in Heart Failure With Preserved Ejection Fraction: Findings From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial (I-PRESERVE). Circulation. S749-S749. 2009
- Combined therapy with angiotensin receptor antagonists and ACE inhibitors versus standard therapy in patients with heart failure: a meta-analysis of randomized controlled trials. European Heart Journal. 165-165. 2009
- Predictors of outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in heart failure with preserved ejection fraction trial (I-PRESERVE). European Heart Journal. 865-865. 2009
- Relationship Between NTproBNP and Exercise Capacity in Chronic Heart Failure: Baseline Data from the HF-ACTION Study. Journal of the American College of Cardiology. A189-A189. 2009
- Prescribing Barriers to Heart Failure Management in Primary Care. Circulation. S1028-S1028. 2008
- Health related quality of life in the Irbesartan in heart failure with preserved systolic function trial (I-PRESERVE). European Heart Journal. 156-156. 2008
- Health related quality of life in I-PRESERVE trial. Journal of Cardiac Failure. S73-S73. 2008
- Anaemia is associated with poor outcome in patients with heart failure and preserved ejection fraction (HF PEF). Findings from the Irbesartan in Heart Failure with Preserved Systolic Function Trial (I-PRESERVE). Circulation. 551-551. 2007
- Atrial fibrillation is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction findings from the irbesartan in heart failure with preserved systolic function trial (I-PRESERVE). Circulation. 706-707. 2007
- Renal dysfunction is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction - Findings from the irbesartan in heart failure with preserved Systolic function trial (I-Preserve). Circulation. 552-552. 2007
- Congestive heart failure assessment and management in primary care (CHAMP-C). Canadian Journal of Cardiology. 298C-298C. 2007
- Baseline plasma NT-proBNP concentrations in relation to clinical characteristics: results from the irbesartan in heart failure with preserved systolic function trial. European Heart Journal. 145-145. 2007
- NT-pro BNP and diastolic dysfunction by echocardiography predicts cardiovascular outcomes in patients with heart failure and preserved systolic function. European Heart Journal. 271-271. 2007
- BNP predicts echocardiographic severity of diastolic dysfunction in heart failure. European Journal of Heart Failure. 10-10. 2007
- NT-proBNP predicts cardiovascular outcomes in patients with heart failure and preserved ejection fraction. European Journal of Heart Failure. 40-40. 2007
- N-terminal pro BNP is associated with cardiac structure and function in elderly patients with heart failure and preserved systolic function; the iPRESERVE study. Journal of the American College of Cardiology. 54A-54A. 2007
- Performance characteristics of BNP and NT-proBNP in the diagnosis of heart failure: A systematic review of the evidence. Clinical Biochemistry. 1101-1101. 2006
- Baseline plasma NT-proBNP concentrations in relation to clinical characteristics: Results from the irbesartan in heart failure with preserved systolic function trial. Circulation. 721-721. 2006
- Cardiac structural changes and diastolic function in heart failure with preserved ejection fraction - Importance of left atrial volume: the iPRESERVE study. Circulation. 816-816. 2006
- The baseline characteristics of patients enrolled in the irbesartan in heart failure with preserved systolic function trial are similar to those in the community but differ from CHARM-Preserved. Journal of Cardiac Failure. S77-S77. 2006
- Diastolic dysfunction in heart failure with preserved systolic - Function need for objective evidence. Results from the CHARM echocardiographic substudy - CHARMES. Circulation. U469-U469. 2005
- Diastolic dysfunction in heart failure with preserved systolic function - need for objective evidence. Results from the CHARM Echocardiographic Substudy - CHARMES. European Heart Journal. 14-14. 2005
- Left ventricular mass is lower with candesartan compared to placebo in patients with heart failure and preserved systolic function. Results from the CHARM echocardiographic substudy - CHARMES. Journal of Cardiac Failure. S152-S152. 2005
- Haemodynamic and neurohormonal effects of AT(1)-receptor blockers. European Heart Journal, Supplement. H49-H54. 2004
- Effect of exercise training on myocardial blood flow in patients with stable coronary artery disease. Circulation. 560-560. 2004
- Impact of candesartan in preventing myocardial infarction: Results of the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) programme. Circulation. 514-514. 2004
- Unrecognized cognitive impairment is common in heart failure outpatients. Circulation. 640-640. 2004
- Response to cardiac rehabilitation after coronary artery bypass graft surgery in patients with and without type 2 diabetes mellitus. European Heart Journal. 507-508. 2004
- Increasing atrial natriuretic peptide over time independently predicts higher short-term mortality and morbidity in heart failure. Journal of the American College of Cardiology. 172A-172A. 2004
- Plasma metalloproteinase levels are correlated with natriuretic peptide and endothelin-1 levels in patients with heart failure. Journal of the American College of Cardiology. 188A-188A. 2004
- Plasma metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in heart failure patients. Circulation. 345-345. 2003
- Prevalence of overweight and obesity in a Canadian cardiac rehabilitation setting. Obesity Research Obesity. A128-A128. 2003
- Neurohumoral changes as markers of progressive left ventricular remodeling in systolic heart failure: Results of the neurohumoral substudy of the randomized evaluation of strategies for left ventricular dysfunction (RESOLVD). Journal of the American College of Cardiology. 141A-141A. 2003
- Benefits of exercise in patients with congestive heart failure. FRONTIERS IN CARDIOVASCULAR HEALTH. 507-517. 2003
- Natriuretic peptides predict left ventricular remodeling in response to metoprolol CR in patients with congestive heart failure: The RESOLVD phase II neurohumoral substudy. Journal of the American College of Cardiology. 139A-139A. 2002
- Angiotensin receptor blockers in heart failure: Meta-analysis of randomized controlled trials. Circulation. 596-596. 2001
- Predictive value of natriuretic peptides and endothelin-1 for LV remodelling in response to candesartan and enalapril: the RESOLVD neurohumoral ancillary study. European Heart Journal. 40-40. 2001
- Predictive value of natriuretic peptides and endothelin-1 for LV remodeling in response to candesartan and enalapril: The RESOLVD neurohumoral ancillary study. Circulation. 27-27. 2000
- Metoprolol in chronic heart failure: Natriuretic peptides involved in mechanism of action?. Circulation. 783-783. 1999
- Single versus double versus triple therapy to block neurohormonal effects on ventricular remodeling. Circulation. 780-780. 1998
- Increased insulin and glucose levels in heart failure (HF). Journal of the American College of Cardiology. 249A-249A. 1998
- Randomized controlled trial of exercise training in patients with congestive heart failure (EXERT). Journal of the American College of Cardiology. 508A-509A. 1998
- Patterns of autonomic dysregulation in congestive heart failure: Relationship with LV function and neurohumoral activation. Circulation. 1909-1909. 1996
- EFFECT OF GLYCOGEN DEPLETION AND LOADING ON SKELETAL-MUSCLE PYRUVATE-DEHYDROGENASE ACTIVATION IN HUMANS DURING EXERCISE. FASEB Journal. A1541-A1541. 1992
- EFFECTS OF ACETAZOLAMIDE (ACZ) ON VENTILATION DURING THE TRANSITION BETWEEN 2 LEVELS OF STEADY-STATE EXERCISE. FASEB Journal. 1004-1004. 1986